Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Breast 2Genitourinary 1Dermatologic 1

Conditions

Prostatic Neoplasms 3Carcinoma, Renal Cell 2Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Lymphoma 1Lymphatic Metastasis 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Magnetic Resonance Spectroscopy 2radium Ra 223 dichloride 1peposertib 1fluoroazomycin arabinoside 1cabozantinib 1avelumab 1Radiotherapy, Image-Guided 1Radiation Dose Hypofractionation 1PITX2 protein, human 1Nomograms 1Nivolumab 1Metastasectomy 1Leuprolide 1Ipilimumab 1Indocyanine Green 1Goserelin 1Docetaxel 1DEAE-Dextran 1CTLA-4 Antigen 1Artificial Intelligence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphatic Metastasis × Indocyanine Green × Genitourinary × Clear all
NCT04882618 2021-05-12

Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.

TC Erciyes University

Phase 4 Unknown
50 enrolled
Genitourinary

Lymphatic Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡